America Finds A Possible Treatment for COVID19

Thursday 30th of April 2020

America Finds A Possible Treatment for COVID19

Gilead Sciences Inc., an American biopharmaceutical company that researches, develops and commercializes drugs, has made remdesivir, a possible treatment for the disease. The government-funded study found that patients who took remdesivir recovered faster than patients who did not.

The US Food and Drug Administration has not yet approved any drugs for the treatment, but it plans to announce an emergency-use authorization for remdesivir, according to The New York Times. "As part of the FDA's commitment to expediting the development and availability of potential COVID-19 treatments, the agency has been engaged in discussions with Gilead Sciences regarding making remdesivir available to patients as quickly as possible, as appropriate," FDA spokesman Michael Felberbaum said in statement.

"The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery," Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, said at the White House during a meeting with President Donald Trump. Results from the preliminary trial show remdesivir improved recovery time for coronavirus patients from 15 to 11 days. So although it can’t cure the disease, it can reduce how long patients are sick.